A GC-MS method for analysis of 8-methoxypsoralen during new immunomodulatory therapy by photopheresis

Chromatographia

Volumn 69, Issue 7-8, 2009, Pages 779-783

  Malakova, Jana ^a   Zak, Pavel ^a   Jokesova, Iveta ^a   Zivny, Pavel ^a   Blazek, Martin ^a   Zavrelova, Alzbeta ^a   Palicka, Vladimir ^a  

^a UNIVERSITY HOSPITAL HRADEC KRALOVE   (Czech Republic)

Author keywords

8 Methoxypsoralen; Gas chromatography mass spectrometry; Photopheresis

Indexed keywords

BERGAPTEN; METHOXSALEN;

ARTICLE; BONE MARROW TRANSPLANTATION; CLINICAL PRACTICE; DRUG DOSE; DRUG STRUCTURE; GAS CHROMATOGRAPHY; GRAFT REJECTION; HUMAN; IMMUNOMODULATION; LIQUID LIQUID EXTRACTION; MASS SPECTROMETRY; PRIORITY JOURNAL; PUVA; VALIDATION PROCESS;

EID: 64249091323     PISSN: 00095893     EISSN: 16121112     Source Type: Journal    
DOI: 10.1365/s10337-008-0924-8     Document Type: Article

References (11)

1. R Dall'Amico L Murer 2002 Transfus Apher Sci 26 197 204 10.1016/S1473-0502(02)00013-7
2. D Peritt 2006 Biol Blood Marrow Transpl 12 7 12 10.1016/j.bbmt.2005.11. 005
3. HP Iperen GMJ Beijersbergen van Henegouwen 1997 J Photochem Photobiol B 39 99 109 10.1016/S1011-1344(96)07432-5
4. CAL Cardoso NK Honda A Barison 2002 J Pharm Biomed Anal 27 217 224 10.1016/S0731-7085(01)00537-4
5. AE Pires NK Honda CAL Cardoso 2004 J Pharm Biomed Anal 36 415 420 10.1016/j.jpba.2004.06.019
6. S Vilhauer A Rudolphi KS Boos D Seidel 1995 J Chromatogr B Anal Technol Biomed Life Sci 666 315 322 10.1016/0378-4347(94)00578-S
7. S Mary P Muret S Makki M Jourdant JP Belon JP Kantelip JC Henry P Humbert 1998 Int J Pharm 161 7 13 10.1016/S0378-5173(97)00290-1
8. L Bräutigam M Seegel I Tegeder H Schmidt S Meier M Podda R Kaufmann M Grundmann-Kollmann G Geisslinger 2003 J Chromatogr B Anal Technol Biomed Life Sci 798 223 229 10.1016/j.jchromb.2003.09.051
9. AT Cracco R Dall'Amico V Ferrari S Bottaro G Zacchello L Chiandetti F Zacchello 1992 J Chromatogr Biomed Appl 574 156 160 10.1016/0378-4347(92)80112-4
10. USFDA (2001) Bioanalytical method validation, guidance for industry. US Department of Health and Human Services, Food and Drug Administration. http://www.fda.gov./cder/guidance/4252fnl.htm
11. N Leveque P Muret S Mary M Berard S Makki JP Kantelip P Humbert 2002 J Chromatogr B Anal Technol Biomed Life Sci 780 119 127 10.1016/S1570-0232(02) 00443-9